MIAMI, FL, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Tuesday, March 31st, 2020.
“We are proud of our achievements in the last quarter of 2019. We are eager to update our shareholders on our current business initiatives during the pandemic and beyond.” says Shital Mars, CEO.
Interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: email@example.com by 5:00 PM EST on Monday, March 30, 2020. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. The questions addressed will be based on the relevance to the shareholder base, and the question’s appropriateness in light of public disclosure rules.
To access the call:
Dial-In Number: 1-857-232-0157 Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/tag/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available at https://progressivecareus.com/investor/.
Connect and stay in touch with us on social media:
Progressive Care Inc. https://www.facebook.com/ProgressiveCareUS/ https://twitter.com/ProgressCareUS
PharmCo Rx https://www.facebook.com/pharmcorx/ https://twitter.com/PharmCoRx
Five Star RX https://www.fivestarrx.com/ https://www.facebook.com/fivestarrx/
About Progressive Care Inc. Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida technology and health services organization that provides prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact: Armen Karapetyan, Progressive Care Senior Advisor Business Development Armen@progressivecareus.com www.progressivecareus.com www.pharmcopharmacy.com
Public Relations Contact: Carlos Rangel firstname.lastname@example.org
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!